Back To: Home : Featured Technology : Stem Cell

CLICK HERE FOR WHAT'S NEW IN:
 

Microarray system advances process for HLA in stem cell and solid organ transplant research
August 2009
SHARING OPTIONS:

Invitrogen, part of Life Technologies Corp.

Invitrogen, part of Life Technologies Corp., has announced the commercial availability of a state-of-the-art, automated, research-use microarray system designed to simplify immunogenetic testing, including human leukocyte antigen (HLA) research. The new Prodigy system is an advanced DNA and protein analysis tool that simplifies and accelerates histocompatibility research, vaccine and drug development and disease association studies. The Prodigy system, a high-throughput, next-generation, sequence-specific oligonucleotide probe system that streamlines sample workflow for hybridizing, detecting and analyzing HLA markers in large-volume variation analysis and genotyping research studies. The Prodigy system has five times the density capacity of current bead-based assays and is enabled by push-button, walk-away automation, enabling researchers to spend valuable time reviewing data or preparing more samples. Prodigy is inherently scalable to include multiplexing capability for more than 500 analytes, while providing high resolution, efficiency and reliability. It is also capable of industry-leading throughput that equates to approximately 290 genotypes in nine hours, and includes integrated software that simplifies data analysis and interpretation.

Invitrogen, part of Life Technologies Corp.
800-955-6288, Option 3, Ext. 46029
www.invitrogen.com


Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.